Cargando…
Efficacy and safety of an NRTI-sparing regimen in antiretroviral-naïve HIV-infected patients: once-daily maraviroc plus lopinavir/ritonavir
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The International AIDS Society
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113053/ http://dx.doi.org/10.1186/1758-2652-13-S4-P5 |
| _version_ | 1782205877320679424 |
|---|---|
| author | Nozza, S Galli, L Di Pietro, M Mazzotta, F Canducci, F Pogliaghi, M Chiappetta, S Galli, A Rusconi, V Salpietro, S Tambussi, G Lazzarin, A |
| author_facet | Nozza, S Galli, L Di Pietro, M Mazzotta, F Canducci, F Pogliaghi, M Chiappetta, S Galli, A Rusconi, V Salpietro, S Tambussi, G Lazzarin, A |
| author_sort | Nozza, S |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3113053 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2010 |
| publisher | The International AIDS Society |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-31130532011-06-13 Efficacy and safety of an NRTI-sparing regimen in antiretroviral-naïve HIV-infected patients: once-daily maraviroc plus lopinavir/ritonavir Nozza, S Galli, L Di Pietro, M Mazzotta, F Canducci, F Pogliaghi, M Chiappetta, S Galli, A Rusconi, V Salpietro, S Tambussi, G Lazzarin, A J Int AIDS Soc Poster Presentation The International AIDS Society 2010-11-08 /pmc/articles/PMC3113053/ http://dx.doi.org/10.1186/1758-2652-13-S4-P5 Text en Copyright ©2010 Nozza et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Poster Presentation Nozza, S Galli, L Di Pietro, M Mazzotta, F Canducci, F Pogliaghi, M Chiappetta, S Galli, A Rusconi, V Salpietro, S Tambussi, G Lazzarin, A Efficacy and safety of an NRTI-sparing regimen in antiretroviral-naïve HIV-infected patients: once-daily maraviroc plus lopinavir/ritonavir |
| title | Efficacy and safety of an NRTI-sparing regimen in antiretroviral-naïve HIV-infected patients: once-daily maraviroc plus lopinavir/ritonavir |
| title_full | Efficacy and safety of an NRTI-sparing regimen in antiretroviral-naïve HIV-infected patients: once-daily maraviroc plus lopinavir/ritonavir |
| title_fullStr | Efficacy and safety of an NRTI-sparing regimen in antiretroviral-naïve HIV-infected patients: once-daily maraviroc plus lopinavir/ritonavir |
| title_full_unstemmed | Efficacy and safety of an NRTI-sparing regimen in antiretroviral-naïve HIV-infected patients: once-daily maraviroc plus lopinavir/ritonavir |
| title_short | Efficacy and safety of an NRTI-sparing regimen in antiretroviral-naïve HIV-infected patients: once-daily maraviroc plus lopinavir/ritonavir |
| title_sort | efficacy and safety of an nrti-sparing regimen in antiretroviral-naïve hiv-infected patients: once-daily maraviroc plus lopinavir/ritonavir |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113053/ http://dx.doi.org/10.1186/1758-2652-13-S4-P5 |
| work_keys_str_mv | AT nozzas efficacyandsafetyofannrtisparingregimeninantiretroviralnaivehivinfectedpatientsoncedailymaravirocpluslopinavirritonavir AT gallil efficacyandsafetyofannrtisparingregimeninantiretroviralnaivehivinfectedpatientsoncedailymaravirocpluslopinavirritonavir AT dipietrom efficacyandsafetyofannrtisparingregimeninantiretroviralnaivehivinfectedpatientsoncedailymaravirocpluslopinavirritonavir AT mazzottaf efficacyandsafetyofannrtisparingregimeninantiretroviralnaivehivinfectedpatientsoncedailymaravirocpluslopinavirritonavir AT canduccif efficacyandsafetyofannrtisparingregimeninantiretroviralnaivehivinfectedpatientsoncedailymaravirocpluslopinavirritonavir AT pogliaghim efficacyandsafetyofannrtisparingregimeninantiretroviralnaivehivinfectedpatientsoncedailymaravirocpluslopinavirritonavir AT chiappettas efficacyandsafetyofannrtisparingregimeninantiretroviralnaivehivinfectedpatientsoncedailymaravirocpluslopinavirritonavir AT gallia efficacyandsafetyofannrtisparingregimeninantiretroviralnaivehivinfectedpatientsoncedailymaravirocpluslopinavirritonavir AT rusconiv efficacyandsafetyofannrtisparingregimeninantiretroviralnaivehivinfectedpatientsoncedailymaravirocpluslopinavirritonavir AT salpietros efficacyandsafetyofannrtisparingregimeninantiretroviralnaivehivinfectedpatientsoncedailymaravirocpluslopinavirritonavir AT tambussig efficacyandsafetyofannrtisparingregimeninantiretroviralnaivehivinfectedpatientsoncedailymaravirocpluslopinavirritonavir AT lazzarina efficacyandsafetyofannrtisparingregimeninantiretroviralnaivehivinfectedpatientsoncedailymaravirocpluslopinavirritonavir |